AGREEMENT TO TERMINATE CLA BETWEEN MONOSOL RX, LLC AND KEMPHARM, INC. DATED AS OF MARCH 20, 2012Agreement to Terminate Cla • November 14th, 2019 • Kempharm, Inc • Pharmaceutical preparations
Contract Type FiledNovember 14th, 2019 Company IndustryThis Agreement to Terminate CLA (“Agreement”), dated as of March 20, 2012 (the “Effective Date”), is between KemPharm, Inc., an Iowa corporation with its principal offices at 7 Hawkeye Drive, Suite 103, North Liberty, Iowa 52317 (“KemPharm”), and MonoSol Rx, LLC, a Delaware limited liability company with its principal offices at 30 Technology Drive, Warren, New Jersey, 07059 (“MSRx”).
AGREEMENT TO TERMINATE CLAAgreement to Terminate Cla • June 27th, 2018 • Aquestive Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 27th, 2018 Company Industry JurisdictionThis Agreement to Terminate CLA (“Agreement”), dated as of March 20, 2012 (the “Effective Date”), is between KemPharm, Inc., an lowa corporation with its principal offices at 7 Hawkeye Drive, Suite 103, North Liberty, Iowa 52317 (“KemPharm”), and MonoSol Rx, LLC, a Delaware limited liability company with its principal offices at 30 Technology Drive, Warren, New Jersey 07059 (“MSRx”).